A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia ...

The 10-minute procedure identified signs of acute myeloid leukaemia (AML) returning in patients before it showed in blood ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

Breeze Hunter thought she simply had a sinus infection she couldn’t kick. It was acute myeloid leukemia, a form of blood ...

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

A new single-cell reference atlas of normal hematopoiesis has helped researchers identify novel acute myeloid leukemia cell ...

A 51-year-old woman who took part in the trial says she feels "incredibly lucky" after a new test detected cancer when a ...

Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).

Phase 1 dose-escalation study to evaluate ziftomenib in combination with imatinib in patients with advanced GIST after imatinib failure – – Combination of ziftomenib and imatinib shows robust and ...

Safety SENTI-202 is generally well tolerated with an adverse event profile that is consistent with other investigational NK cell therapies and patients with underlying AML receiving ...

The new treatment, which uses a type of immune cell called natural killer cells, promoted complete remission in several ...